United States Army Medical Research Institute of Chemical Defense
The Center for Catalytic Bioscavenger Medical Defense Research
CENTER OF EXCELLENCE NIH Grant 5U54-NS058183
 

The United States Army Medical Research Institute of Chemical Defense (USAMRICD) is the lead laboratory for medical chemical defense research for the Department of Defense and our nation.

The mission of the Institute includes the development of Bioscavengers against organophosphorus nerve agents.

In response to the Countermeasures Against Chemical Threats (CounterACT) program, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), the USAMRICD, in collaboration with five partner institutions, was awarded a Center of Excellence Grant to develop catalytic bioscavengers to protect civilian populations from chemical threat agents.


Funding Partners:




National Institute of Health




National Institute of Neurological
Disorders and Stroke




CounterACT
Project Partners:
Project 1

USAMRICD
Project 2

Human Biomolecular
Research Institute
Project 3

The Weizmann Institute
Project 4

Department of Chemistry
The Ohio State University
Project 5

The Biodesign Institute of
Arizona State University
Project 6

Department of Plant,
Cellular and Molecular Biology
The Ohio State University